FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 30 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,603 | -44.7% | 93,309 | -0.7% | 0.00% | – |
| Q2 2023 | $438,793 | +29.6% | 93,960 | +4.6% | 0.00% | – |
| Q1 2023 | $338,493 | +71.5% | 89,786 | +43.3% | 0.00% | – |
| Q4 2022 | $197,429 | +19.7% | 62,676 | +14.2% | 0.00% | – |
| Q3 2022 | $165,000 | +223.5% | 54,904 | +167.1% | 0.00% | – |
| Q2 2022 | $51,000 | -69.1% | 20,554 | -3.5% | 0.00% | – |
| Q1 2022 | $165,000 | – | 21,300 | +45219.1% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 47 | -98.9% | 0.00% | – |
| Q3 2021 | $35,000 | +12.9% | 4,298 | +12.4% | 0.00% | – |
| Q2 2021 | $31,000 | -67.7% | 3,825 | -30.3% | 0.00% | – |
| Q2 2020 | $96,000 | – | 5,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $11,562 | 3.36% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $9,285,598 | 3.10% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4,917,100 | 2.14% |
| Sio Capital Management, LLC | 260,448 | $820,411 | 0.30% |
| BRAIDWELL LP | 2,000,000 | $6,300,000 | 0.21% |
| Orbimed Advisors | 3,224,770 | $10,158,026 | 0.19% |
| TPG GP A, LLC | 2,551,794 | $8,038,151 | 0.16% |
| Artal Group S.A. | 750,000 | $2,363 | 0.13% |
| RA Capital Management | 659,992 | $2,078,975 | 0.04% |
| SECTORAL ASSET MANAGEMENT INC | 57,297 | $180,486 | 0.04% |